News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Maat Pharma Secures European Medicines Agency Orphan Drug Designation for MaaT033, With a Focus on Enhancing Survival in Hematopoietic Stem Cell Transplantation Patients
Friday, September 08, 2023MaaT Pharma a clinicalstage biotechnology firm traded on EURONEXT under the symbol MAAT has announced that the European Medicines Agency EMA has granted orphan drug designation ODD for their product MaaT
Actimed Therapeutics Receives FDA Approval for Phase 2b/3 IMPACT Clinical Trials Evaluating S-pindolol Benzoate as a Treatment for Cancer Cachexia
Friday, September 08, 2023Actimed Therapeutics Ltd a UKbased pharmaceutical company with a focus on innovative treatments for cancer cachexia and muscle wasting disorders has received approval from the US FDA for its Investigational New Drug IND application
Myricx and Biocytogen Announce Antibody Licensing Partnership
Friday, September 08, 2023Myricx Bio a prominent UK biotech company specializing in the exploration and development of a groundbreaking class of selective cytotoxic payloads for antibody drug conjugates ADCs has announced a significant antibody license agreement with Biocytog...
Lupin, in Collaboration With Mark Cuban's Cost Plus Drug Company and the COPD Foundation, Aims to Improve Medication Accessibility for COPD Patients
Thursday, September 07, 2023Lupin Limited a global pharmaceutical company has formed a unique partnership with the Mark Cuban Cost Plus Drug Company Cost Plus Drugs and the COPD Foundation with the goal of improving healthcare access for COPD patients in the United States
FDA Approves Phase 2 Trial of RLS-0071 in Hospitalized Patients With Steroid-refractory Acute Graft-versus-host Disease by Realta Life Sciences
Thursday, September 07, 2023ReAlta Life Sciences Inc known as ReAlta is a clinicalstage biotechnology company that focuses on harnessing the immune systems potential to combat lifethreatening diseases
Arcturus Therapeutics and CSL's ARCT-154 COVID-19 Vaccine Application for Marketing Authorization Receives Validation From European Medicines Agency
Wednesday, September 06, 2023Arcturus Therapeutics Holdings Inc Nasdaq ARCT is a global biopharmaceutical company specializing in the development of messenger RNA mRNA medicines CSL ASX CSL a leading provider of influenza vaccines operates through its vaccine business CSL Seqiru...
Inmune Bio Inc. Receives Approval From the U.K. Medicines and Healthcare Products Regulatory Agency for Phase 2 Clinical Trial in Alzheimer's Disease
Wednesday, September 06, 2023INmune Bio Inc NASDAQ INMB a clinicalstage immunology company dedicated to developing treatments that harness the innate immune system to combat diseases has received approval from the Medicines and Healthcare products Regulatory Agency MHRA to initi...
Esocap Achieves Full Patient Enrollment in Phase II ACESO Trial for Eosinophilic Esophagitis
Tuesday, September 05, 2023Swiss biotech company EsoCap AG has announced the successful completion of patient recruitment for the Phase II ACESO trial This study is a randomized placebocontrolled doubleblind investigation into the efficacy tolerability and safety of their prod...
Invios Commences Additional Clinical Trial for APN401, an Innovative Cell Therapy for Solid Tumors, and Secures Substantial Research Grant From Austria
Tuesday, September 05, 2023InvIOs GmbH a privately owned biotechnology firm dedicated to pioneering cancer therapies has initiated the recruitment of patients for a Phase b clinical trial of its innovative autologous cell therapy APN This trial aims to enroll patients with sol...
Advancements in Dipraglurant Research for Post-stroke Recovery by Addex Supported by Findings in Brain Journal
Monday, September 04, 2023Addex Therapeutics SIX and Nasdaq ADXN a clinicalstage pharmaceutical company specializing in allosteric modulationbased drug discovery and development has disclosed new findings published in the journal Brain
